Antimicrobial therapy has made few more dramatic conquests than that of bacterial meningitis, which it has transformed from the almost universally fatal illness of 30 years ago into one with a relatively low mortality. Yet the disease, which has its greatest impact in early childhood, poses a continuing threat and must be regarded as one of the most challenging of medical emergencies. In the United Kingdom and Eire in 1973, at least 109 children under 15 years of age were reported to have died from it (Public Health Laboratory Service, 1974; ) and in the United States more than a quarter of survivors from Haemophilus influenzae meningitis alone have been found to have significant neurological handicaps (Sproles et al., 1969; Sell et al., 1972a) .
Moreover, survivors of that illness considered normal by their physicians and families functioned significantly less well on a battery of ,tests than matched controls from the same classrooms at school (Sell et al., 1972b) . Though such disappointing results are by no means the rule (Lawson, Metcalfe, and Pampiglione, 1965) , even more unfavourable reports come from follow-up of survivors of neonatal meningitis. It is important then to keep under review old and new methods of treatment and newer aids to diagnosis if this hard core of death and disability is to be reversed. We shall concentrate mainly, though not exclusively, on diagnosis and management of bacterial meningitis, and refer readers elsewhere for a wider discussion of other aspects (Hambleton and Davies, 1974 ).
Children at special risk Children aged 6 months to 1 year are at greatest risk (Fraser et al., 1973) ; and it has been estimated that over 80% of all cases occur in the first 5 years of life, with 35 % in the first year Mathies, 1971 Mathies, -1972 Yow et al., 1973) . Poor socioeconomic conditions (Fraser et al., 1973) , the male sex (Washburn, Medearis, and Childs, 1965) , congenital anomalies of or injury to the central nervous system, and primary infection elsewhere, especially that adjacent to the meninges, are other well established predisposing factors. Children who have impaired defence mechanisms for a variety of reasons are a tiny minority but are neverthe less being kept alive in increasing numbers for much longer now, and are consequently in jeopardy. For instance, an association between pneumococcal infection and sickle cell disease, a condition which may be associated with a defect in the properdin system (Johnston, Newman, and Struth, 1973 ) is well known, and Smith et al. (1973) have calculated that 1 in every 27 children with the disease may develop pneumococcal meningitis by the age of 4 years. Others with the rare inborn erret of host defence, and children being treated with immunosuppressant and cytotoxic drugs for such conditions as leukaemia, malignant disease, and the nephrotic syndrome are all more liable to bacterial infection. In the newborn, low birthweight, a prolonged interval between membrane rupture and delivery, and a complicated obstetric and neonatal course are all factors which may be associated with a later development of meningitis.
Bacterial meningitis mortality when the pathogen contains KL capsular polysaccharide antigen compared with non-KI strains (McCracken et al., 1974) . The emergence of the group B P-haemolytic streptococcus, now ranked second in importance to Esch. coli as a cause of neonatal meningitis in the United States (Barton, Feigin, and Lins, 1973) , has been recent. Older children with impaired host defense share with the newborn a liability to infection with opportunist invaders such as Pseudomonas aeruginosa; and those who have cerebrospinal fluid shunts are most likely to be infected with Staphylococus albus. Organisms causing meningitis in childhood, and the currently appropriate antibacterial drugs for treatment are shown in Table I .
It is worth discussing the two principal offenders, H. influenzae and N. meningitidis, in greater detail. Of the various encapsulated strains of H. influenzae, type b is responsible for almost all cases ofmeningitis (Turk and May, 1967) , and the disease has become more common in recent years (Michaels, 1971; Smith and Haynes, 1972) . Defence mechanisms have recently been summarized by Coulter, Whisnant, and Marks (1974) in their discussion of haemophilus meningitis in the identical twin pair of a triplet sibship. Both anticapsular and/or bactericidal antibody, and genetic factors associated with the distribution of white and red cell antigens may determine individual susceptibility. Many years ago Fothergill and Wright (1933) showed that the blood's bactericidal activity to H. influenzae was age dependent, and that adult levels were not reached until 7 years. Recently, Graber et al. (1971) found that only 25% of mothers possessed such bactericidal antibodies compared with 90% previously, and consequently postulated a shift in neonatal susceptibility due to absence of the antibodies in the placentally transferred IgG fraction of immunoglobulins. Though their findings have been disputed on technical grounds (Mpairwe, 1972) , others have cited similar evidence (Norden, Callerame, and Baum, 1970 Schiffer et al., 1974;  Thomsberry and Kirven, 1974; Clymo and Harper, 1974; Turk, 1974; Williams and Cavanagh, 1974; Schulte and Vollrath, 1974) . Many sources have been consulted in compiling this data and are referrred to in full in Hambleton and Davies (1974) . Erythromycin: the intramuscular preparation is very irritant and should be avoided whenever possible. The drug is only necessary when the patient is penicillin-sensitive, or if infected with a methicillin-resistant Staph. aureus. These organisms are usually also resistant to cloxacillin and the cephalosporins.
Co-trimoxazole (sulphamethoxazole-trimethoprim): isolated case reports suggest this may prove to be a useful drug in treatment of meningitis. A dose of 30-40 mg sulphamethoxazole, 6-8 mg triL-.iethoprim/kg per d is said to give high levels in serum and CSF (Sabel and Brandberg, 1975 (British Medical Journal, 1974; Lancet, 1974) . Group B strains may be particularly important under 1 year of age, wheras C strains are more prevalent in later childhood (McCormick et al., 1974 ). It appears that the acquisition rate of N. meningitidis-the number of new carriers over a short period of time-is more important than the carrier rate (Wenzel et al., 1973) , and Fallon (1974) has pointed out that as in poliomyelitis, meningococcal infection is really a 'failure of carriage'. Meningococcal meningitis has increased significantly in the last few years (British Medical Journal, 1974; Lancet, 1974) . Sulphonamide-resistant strains of N. meningitidis have been noted since 1943 (Feldman, 1972) and are now predominant in the United States. Bennett and Young (1969) found such resistance to 92% of group C, 72% of group A, and 41% of group B strains. Sulphonamide-resistance is still relatively uncommon in Britain (Abbott and Graves, 1972) , but the extent is debatable (Fallon, 1974; Jones and Abbott, 1974; Emond and Smith, 1974 (Kenny, 1973) . Most bacteria have the ability to convert to this form if cell wall synthesis is not favoured by environmental conditions, so that they become resistant to antibiotics inhibiting such synthesis. However, Kenny did not find L forms to be associated with meningitis taking a prolonged or relapsing course. Diagnosis The first essential for improved results is early diagnosis, and it is in the younger child and infant that delay most often occurs. The early signs of meningitis are entirely nonspecific in the newborn, and unless the disease is positively excluded when they appear, or before any antibiotic therapy is started, mortality and morbidity rates will continue to be high. In the older infant, too, such signs as neck stiffness, a bulging fontanelle, and altered sensorium are not present initially. The longcherished belief of one of us-that the disappearance of the spontaneous social smile of the infant was a constant feature of early meningitis-has recently been rudely shattered; a cheerful countenance and Esch. coli in the cerebrospinal fluid (CSF) are not mutually exclusive. There are several helpful analyses of the early signs of meningitis to which we refer our readers (Smith, 1956; Heycock and Noble, 1964; Smith et al., 1973 Routine examination of CSF. Lumbar puncture is obligatory. Papilloedema is not a contraindication provided only 1-2 ml of CSF are removed. Though there is some experimental work to show that meningitis can be produced if cistemal puncture is done within 2 minutes of an intravenous dose of infecting organisms (Petersdorf, Swarner, and Garcia, 1962) there is little evidence in the human that lumbar puncture causes meningitis if bacteraemia or septicaemia are present (Pray, 1941) , and it, or cisternal or ventricular puncture if necessary, should always be performed. The greatest care should be taken over the procedure in very sick children with cardiac or respiratory disease (Margolis and Cook, 1973) . A stylettedneedle should always be used (Joyner, Idriss, and Wilfert, 1974) . Gram-stain and differential cell count give the most useful information initially, and there are few if any situations in which the immediate help of an experienced bacteriologist is more necessary. The method of Gram-staining involves washing the stains at a certain stage, and can be misleading when performed by the inexperienced. The pleomorphism of H. influenzae must also be remembered. The cell count in bacterial meningitis may range from 10 cells to 100000/mm3, and in viral meningitis from 15-2000/mm3. (Meade, 1963 (Feinbloom and Alpert, 1969) , which may be the case in very early meningitis (Moore and Ross, 1973) . The levels may also be normal when cells and bacteria are present in significant quantities. The factors influencing the amount of glucose in the CSF are complex and and not fully understood (Menkes, 1969 This techniqueallows detectionof bacterial antigen in the CSF by the use of specific antisera against the common pathogens, and can offer a result within 1-2 hours. The patient's CSF is exposed to the various antisera placed in wells in a suitable gel across which an electric field is exerted. The appearance of precipitation lines indicates a positive result. The reliability of the method rests on the specificity of the antisera, which should ideally be prepared from locally-occurring bacteria in the area of the hospital concerned. There are reports of the successful application of this technique in meningitis due to H. influenzae (Edwards, Muehl, and Peckinpaugh, 1972) and N. meningitidis (Greenwood, Whittle, and Dominic-Rajkovic, 1971; Tobin and Jones, 1972 (Fox et al., 1969) , and antisera-coated latex particles (Newman, Stevens, and Gaafar, 1970; Goodman, Kaufman and Koenig, 1971) .
(c) Limulus tests for endotoxaemia. A lysate prepared from the horshoe crab, Limulus polyphemus, will form a gel in the presence of endotoxin, thus allowing nonspecific detection of Gramnegative organisms (Nachum, Lipsey, and Siegel, 1973 (Kaldor and Ferris, 1969; Smith et al., 1973) .
CSF IgM is also raised in noninfective inflammatory disease of the central nervous system Kolar and Ross, (1973) .
(e) CSF enzymes. Levels of lactic dehydrogenase and glutamo-oxaloacetic transaminase are raised in bacterial, though not in viral, meningitis (Williams and Hawkins, 1968; Neches and Platt, 1968; Shoeb et al., 1970 (Winkelstein, 1970; Jarvis and Saxena, 1972; Converse et al., 1973) show that the rate of bacteriologically positive CSF is only some 10% less in treated patients as compared with untreated. In practical terms the clinician is faced with the problem of aetiology rather than diagnosis: the CSF is virtually always abnormal, and the difficulty lies often not in deciding whether meningitis is present, but whether it is viral (or very rarely tuberculous) or bacterial. Though they can usually be distinguished on levels of protein, glucose, and cell type and number, there is considerable overlap, and as already stated an early polymorph preponderance in some cases of viral meningitis can be confusing. Feigin and Shackelford (1973) Table I) should be used. If such evidence is not forthcoming immediately and uncertainty exists, it is necessary after the first 2 or 3 months of life to cover the three common pathogens-H. influenzae, N. meningitidis, and Dip. pneumoniae.
Ampicillin alone ) and chloramphenicol alone (Murray et al., 1972) have been used successfully. Ampicillin has been shown to be as effective singly at a dose of 150 mg/kg per day as combined with chloramphenicol 100 mg/kg per day and streptomycin 40 mg/kg per day, the latter for 2 days only . However, an ampicillin dosage of 300-400 mg/kg per day has also been recommended (Barrett et al., 1966) in view of reports of relapses of H. influenzae meningitis. This problem is discussed in more detail below. In experimental meningitis a bacteriostatic drug such as chloramphenicol has been shown to interfere with the action of a bactericidal one such as penicillin, and there may be some support for this in clinical practice . In the first months of life a combination of ampicillin and gentamicin is to be preferred. Hoyne (1953) found more favour (e.g. Smith, 1956 ) than supporters (Weinstein, Goldfield, and Adamis, 1953; McKendrick, 1954) . In one British series with generally good follow-up results (Lawson et al., 1965) intrathecal therapy was more often used initially and has its continued advocates (Lorber, 1974 Spies, 1957-1968; deLemos and Haggerty, 1969) . It is known that most children have raised levels of plasma cortisol in meningitis (Migeon et al., 1967 (Jalling, 1974 ) but 1-4 days are required for phenytoin, though larger loading doses can be used to achieve an effect within 24 hours (Wilder, Serrano, and Ramsay, 1973) . A careful watch on blood pressure should be kept because of the risk of drug-induced hypotension. There is a reduction in regional cerebral blood flow and in cerebral metabolic rate of oxygen in adults with meningitis (Paulson et al., 1974) , and there is no reason to suppose these findings are not relevant to children. Thus any factors leading to hypotension or hypertension, hypercapnia, hypoxia, and increased cerebral metabolism are to be avoided whenever possible.
Cerebral oedema. This is likely to be a consequence both of hypoxia and of the infection and therefore to some extent preventable if the meningitis is diagnosed early and treated vigorously. If established, dexamethasone (0-5 mg/kg per d) for 48 hours or other corticosteroids (Reynolds, 1966) have been advocated. Mannitol 20% in a dose of 1-1 -5 mg/kg in 20-30 minutes has also been used in meningitis (Murray et al., 1972 (Yow, 1969; Wehrle, Mathies and Leedom, 1969 As we go to press we marginally favour chloramphenicol. Lorber (1974) states that he has had no deaths with his method of treatment. If he can prove on detailed assessment at follow-up that neurological sequelae are also fewer than those recently reported, then his advocacy of initial intrathecal treatment may find wide support.
Meningococcal meningitis. The drug of choice is benzylpenicillin, and the initial dose 250 000 units/kg per day, given 4 or 6 hourly intravenously. It is no more effective than sulphonamides alone (Lepper et al., 1952; Stiehm and Damrosch, 1966) , providing of course that the organisms involved are sulphonamide sensitive, but since the possibility of resistant organisms exists, the sulphonamides need not now be used in treatment at all. Ampicillin and chloramphenicol are also effective. In a controlled trial of the treatment of sulphonamide-resistant group A meningococcal meningitis in Africa, the latter proved as effective as, and much cheaper than, penicillin, for adults and older children were soon able to take it by mouth which reduced the cost and simplified treatment, both factors of overriding importance in that country (Whittle et al., 1973) .
Patients with meningococcal septicaemia have a bad prognosis (Stiehm and Damrosch, 1966) , particularly if meningitis is not present. Treatment for shock may be necessary and in some cases disseminated intravascular coagulation occurs (Fox, 1971) . Various authors have reported the successful use of heparin in this condition (Abildgaard et al., 1967; Winkelstein et al., 1969; Ellman, 1971) , while others have reported failure (Hitzig, 1964; McGehee, Rapaport, and Hjort, 1967) . Patients have survived the condition without the use of heparin (Corrigan, Jordan, and Bennett, 1973) . It is not possible to give general advice about the treatment of disseminated intravascular coagulation, except to say that clear laboratory evidence of its occurrence must be obtained before considering the use of heparin.
Pneumococcal meningitis. Benzylpenicillin is again the drug of choice, with ampicillin an acceptable alternative . The previously favoured triple combination of benzylpenicillin, sulphonamides, and chloramphenicol is no more effective (Weiss et al., 1967) . Benzylpenicillin can be given intravenously in the same dosage as for meningococcal meningitis. If intrathecal therapy is given for the first few days, CSF levels of the drug must be carefully monitored, particularly in the youngest patients and those with underlying disease, for their mechanisms for metabolism and excretion of drugs may be impaired, with druginduced cerebral toxicity a real possibility. Beyond the neonatal period the intrathecal dose of benzylpenicillin can range from 2000-10 000 units, depending on age. Relapsing pneumococcal meningitis, associated with the isolation of an organism with decreased susceptibility to benzylpenicillin, in a child with sickle cell disease has recently been reported (Naraqi, Kirkpatrick, and Kabins, 1974) .
Staphylococcal meningitis. In the early 1950s, when most newborn babies left maternity units colonized with Staphylococcus aureus, meningitis associated with this organism was by no means unknown, but it is rare at older ages (Finland, Jones, and Barnes, 1959; Quaade and Kristensen, 1962) . Cloxacillin and methicillin are still the most appropriate drugs for most of the penicillinaseproducing strains. Children with CSF shunts are at risk from meningitis, and particularly that caused by Staphylococcus albus. In general the same antibiotics are suitable, but recent trials have shown that systemic therapy alone is unlikely to be curative (Shurtleff et al., 1974) . These authors state that the initial treatment should be both systemic and intraventricular, providing the shunt system inincludes a reservoir allowing direct access to the CSF. However, complete shunt replacement using the opposite ventricle and a different distal shunt site in addition may be essential for cure.
Neonatal meni:igitis. Neonatal meningitis is characterized by a very wide range of infecting organisms, and there can be few bacterial species which have not been responsible for the disease. Satisfactory cure can follow intramuscular treatment alone (Zoumboulakis et al., 1973) . However, late diagnosis is too often made, and preliminary results of the U.S. Cooperative Neonatal Meningitis Study Group suggest that for meningitis due to Gramnegative enteric bacteria, uncorrected mortality is lower with intrathecal treatment, though this improvement is offset by a higher rate of serious sequelae (McCracken, 1975) . Nevertheless, at present initial systemic treatment with ampicillin and gentamicin, and intrathecal treatment with gentamicin offer the most favourable combination for all eventualities, and should be given without delay. Chloramphenicol would be an acceptable alternative for most of the more commonly encountered organisms with the exception of Pseudo-monas aeruginosa. Once the infecting organims is known with certainty, modification may be necessary. For instance, benzylpenicillin would be the drug of choice for meningitis caused by group B ,B-haemolytic streptococci, usually a maternally transmitted infection. Carbenicillin and gentamicin should be used for Ps. aeruginosa infections.
CSF in meningitis due to Gram-negative organisms may show positive cultures for several days after treatment is started depite adequate antibiotic concentrations, whereas in that due to Gram-positive organisms it is usually promptly sterilized (McCracken, 1972 ). Daily intrathecal therapy should continue for 4-5 days after the last positive culture. Systemic therapy should probably be given for a total of 14-21 days, depending on progress. If the lumbar fluid is sterile, but clinical progress unsatisfactory, the possibility of a persisting ventriculitis should be remembered (Berman and Banker, 1966) , and if present, therapy must be continued intraventricularly. Dosage for the neonatal period is given in Table II Lorber, Kalhan, and Mahgrefte (1970) state that much higher doses are needed, given intraventricularly, to achieve bactericidal concentrations in CSF. They have used up to 8 mg gentamicin and up to 20 mg cloxacillin in this situation.
Co-trimoxazole (sulphamethoxazole-trimethoprim): isolated case reports suggest this may prove to be a useful drug in treatment of meningitis, though it should be avoided in the first week, and in very immature or jaundiced newborn infants. A dose of 30-40 mg sulphamethoxazole, 6-8 mg trimethoprim/kg per day is said to give high levels in serum and CSF (Sabel and Brandberg, 1975 (Lancet, 1974) , which makes their use less attractive.
Although penicillin is so effective in the mangement of meningococcal meningitis it does not eradicate the organism, and successfully treated cases may return home still carrying it in the nasopharynx (Khuri-Bulos, 1973) . Discussing this situation, Feldman (1975) 
